These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study. Ehrensing RH; Kastin AJ Arch Gen Psychiatry; 1974 Jan; 30(1):63-5. PubMed ID: 4587068 [No Abstract] [Full Text] [Related]
3. Letter: Lithium and haloperidol in movement disorders. McCaul JA; Stern GM Lancet; 1974 May; 1(7865):1058. PubMed ID: 4133743 [No Abstract] [Full Text] [Related]
4. Management of tardive dyskinesia with thiopropazate. Curran JP Am J Psychiatry; 1973 Aug; 130(8):925-7. PubMed ID: 4146097 [No Abstract] [Full Text] [Related]
5. Tardive dyskinesia: side effect or not? Curran JP Am J Psychiatry; 1973 Apr; 130(4):406-10. PubMed ID: 4144163 [No Abstract] [Full Text] [Related]
9. Lithium carbonate in the treatment of tardive dyskinesia. Reda FA; Escobar JI; Scanlan JM Am J Psychiatry; 1975 May; 132(5):560-2. PubMed ID: 804260 [TBL] [Abstract][Full Text] [Related]
11. Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: mechanisms of oxytocin inactivation. Walter R; Griffiths EC; Hooper KC Brain Res; 1973 Oct; 60(2):449-57. PubMed ID: 4587290 [No Abstract] [Full Text] [Related]
12. Treatment of tardive dyskinesia. Widroe HJ; Heisler S Dis Nerv Syst; 1976 Mar; 37(3):162-4. PubMed ID: 3393 [TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of thyrotropin releasing hormone in animals and man: a generic hypothesis. Prange AJ; Wilson IC Psychopharmacol Bull; 1975 Jan; 11(1):22-4. PubMed ID: 804704 [No Abstract] [Full Text] [Related]
14. Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial. Gerlach J; Thorsen K; Munkvad I Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):51-6. PubMed ID: 788002 [TBL] [Abstract][Full Text] [Related]
15. Estrogen influence on the hypothalamic enzymes involved in the formation of melanocyte-stimulating hormone release-inhibiting factor (MSH-R-IF). Celis ME; Taleisnik S Proc Soc Exp Biol Med; 1974 Jan; 145(1):142-4. PubMed ID: 4591390 [No Abstract] [Full Text] [Related]
16. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides. Castensson S; Sievertsson H; Lindeke B; Sum CY FEBS Lett; 1974 Aug; 44(1):101-5. PubMed ID: 4212370 [No Abstract] [Full Text] [Related]
17. Site of inactivation of melanocyte-stimulating hormone-release-inhibiting hormone by human plasma. Nair RM; Redding TW; Kastin AJ; Schally AV Biochem Pharmacol; 1973 Aug; 22(15):1915-9. PubMed ID: 4578947 [No Abstract] [Full Text] [Related]